Glomerular C4d deposition indicates in situ classic complement pathway activation, but is not a marker for lupus nephritis activity
- PMID: 12619178
- DOI: 10.3349/ymj.2003.44.1.75
Glomerular C4d deposition indicates in situ classic complement pathway activation, but is not a marker for lupus nephritis activity
Abstract
This study was designed to evaluate whether glomerular C4d deposition may be a useful marker of lupus nephritis activity. Twenty-one patients diagnosed as having lupus nephritis (WHO class III: 4 cases; IV: 12 cases; V: 5 cases) were included. Mean patient age was 29.3 +/- 13.5 years (range: 7-55 years). The presence and intensity of glomerular C4d deposition were compared with the corresponding histologic activity index for each case. Immunofluorescence for C4d showed diffusely granular staining along glomerular capillary loops, in all cases examined (1+, in 8 cases; 2+, in 7 cases; 3+, in 6 cases). In eight cases, C4d deposition was found in the absence of capillary or mesangial C4 deposits. Moreover, the intensity of C4d deposits correlated with those of capillary IgG, IgA, C4, C1q, and fibrinogen deposits. However, C4d staining intensity did not correlate with the lupus nephritis activity index. Although glomerular capillary C4d deposition is a sensitive marker of classic complement pathway activation, it is not a sensitive marker for active lupus nephritis.
Similar articles
-
Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.Ren Fail. 2013;35(2):222-5. doi: 10.3109/0886022X.2012.743916. Epub 2012 Nov 26. Ren Fail. 2013. PMID: 23176021
-
Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.Int J Clin Exp Pathol. 2013 Sep 15;6(10):2157-67. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24133594 Free PMC article.
-
Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.Arthritis Rheum. 2008 Aug;58(8):2460-9. doi: 10.1002/art.23662. Arthritis Rheum. 2008. PMID: 18668574
-
Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis.Lupus. 2024 Feb;33(2):111-120. doi: 10.1177/09612033231226351. Epub 2024 Jan 16. Lupus. 2024. PMID: 38227433 Review.
-
C4d in Native Glomerular Diseases.Am J Nephrol. 2019;49(1):81-92. doi: 10.1159/000496059. Epub 2019 Jan 4. Am J Nephrol. 2019. PMID: 30612132 Review.
Cited by
-
Renal C4d is a potential biomarker of disease activity and severity in pediatric lupus nephritis patients.Front Pediatr. 2023 Jun 1;11:1193917. doi: 10.3389/fped.2023.1193917. eCollection 2023. Front Pediatr. 2023. PMID: 37325343 Free PMC article.
-
C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy.Front Med (Lausanne). 2022 Jan 31;9:832998. doi: 10.3389/fmed.2022.832998. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35174193 Free PMC article.
-
The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients.Front Immunol. 2021 Jul 1;12:654652. doi: 10.3389/fimmu.2021.654652. eCollection 2021. Front Immunol. 2021. PMID: 34276649 Free PMC article.
-
Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.Clin Rheumatol. 2021 Jun;40(6):2233-2242. doi: 10.1007/s10067-020-05499-1. Epub 2020 Nov 10. Clin Rheumatol. 2021. PMID: 33170371
-
Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies.Kidney Int Rep. 2019 Jul 30;4(11):1555-1567. doi: 10.1016/j.ekir.2019.07.015. eCollection 2019 Nov. Kidney Int Rep. 2019. PMID: 31890997 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
